Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2-low breast cancers: Current insights and future directions.
Zhang H, Karakas C, Tyburski H, Turner BM, Peng Y, Wang X, Katerji H, Schiffhauer L, Hicks DG. Zhang H, et al. Among authors: katerji h. Semin Diagn Pathol. 2022 Sep;39(5):305-312. doi: 10.1053/j.semdp.2022.07.003. Epub 2022 Jul 9. Semin Diagn Pathol. 2022. PMID: 35872032 Review.
HER2-Low Breast Cancers.
Zhang H, Katerji H, Turner BM, Hicks DG. Zhang H, et al. Among authors: katerji h. Am J Clin Pathol. 2022 Mar 3;157(3):328-336. doi: 10.1093/ajcp/aqab117. Am J Clin Pathol. 2022. PMID: 34519765 Review.
The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing.
Turner BM, Finkelman BS, Hicks DG, Numbereye N, Moisini I, Dhakal A, Skinner K, Sanders MAG, Wang X, Shayne M, Schiffhauer L, Katerji H, Zhang H. Turner BM, et al. Among authors: katerji h. Cancers (Basel). 2023 Jan 31;15(3):903. doi: 10.3390/cancers15030903. Cancers (Basel). 2023. PMID: 36765860 Free PMC article.
HER2 in uterine serous carcinoma: Current state and clinical perspectives.
Navarro Sanchez JM, Finkelman BS, Turner BM, Katerji H, Wang X, Varghese S, Wang T, Peng Y, Hicks DG, Zhang H. Navarro Sanchez JM, et al. Among authors: katerji h. Am J Clin Pathol. 2023 Oct 3;160(4):341-351. doi: 10.1093/ajcp/aqad056. Am J Clin Pathol. 2023. PMID: 37267036 Review.
Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomas.
Navarro Sanchez JM, Finkelman BS, Tyburski H, Turner BM, Moisini I, Katerji H, Varghese S, Wang X, Schiffhauer LM, Chen JJ, Hicks DG, Zhang H. Navarro Sanchez JM, et al. Among authors: katerji h. Hum Pathol. 2024 May 11;148:51-59. doi: 10.1016/j.humpath.2024.05.002. Online ahead of print. Hum Pathol. 2024. PMID: 38740270
ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor.
Xiao GQ, Li F, Unger PD, Katerji H, Yang Q, McMahon L, Burstein DE. Xiao GQ, et al. Among authors: katerji h. Mod Pathol. 2016 Jun;29(6):591-8. doi: 10.1038/modpathol.2016.46. Epub 2016 Feb 26. Mod Pathol. 2016. PMID: 26916077 Free article.
16 results